Estimation of silver-binding nucleolar organizer regions (AgNORs) in lymphoproliferative disorders of gastrointestinal tract. 1994

H Takahashi, and S Fujita, and H Okabe, and N Tsuda, and F Tezuka
Department of Oral Pathology, Nagasaki University School of Dentistry, Japan.

We quantified nucleolar organizer regions demonstrable by silver staining technique (AgNORs) in six cases of reactive lymphoid hyperplasia (RLH), and in 14 low-grade B-cell lymphomas (mucosa-associated lymphoid tissue (MALT) 5, centrocytic 3, centroblastic-centrocytic 6) and 49 high-grade B-cell lymphomas (centroblastic 44, immunoblastic 3, Burkitt's one, large cell anaplastic one). The pooled mean AgNOR number in low-grade B-cell lymphomas was significantly higher than that in RLH, and significantly lower than that in high-grade B-cell lymphomas. There was a statistically significant difference between RLH versus centroblastic-centrocytic lymphoma in pooled mean AgNOR number and in RLH versus centrocytic lymphoma but not in RLH versus MALT lymphoma. The AgNOR numbers in the cellular components of RLH were also analyzed. The follicle center centroblasts of RLH exhibited a significantly higher pooled mean AgNOR number than other kinds of lymphoid cells in RLH. Furthermore, AgNOR numbers of gastrointestinal lymphomas were compared with those of cellular elements in RLH. There was a statistically significant increased AgNOR number of centroblastic lymphoma when compared with neoplastic centroblasts in centroblastic-centrocytic lymphoma and follicular centroblasts in RLH. By contrast, there was no significant difference in AgNOR numbers between MALT lymphomas and interfollicular lymphocytes, mantle zone lymphocytes or follicular centrocytes in RLH, respectively. This study demonstrated a similar increase when non-Hodgkin's B-cell lymphomas in gastrointestinal tract were compared with histogenetically related cellular elements of RLH. AgNOR counting might be useful adjunct in the classification and grading of lymphoproliferative disorders in gastrointestinal tract.

UI MeSH Term Description Entries
D008232 Lymphoproliferative Disorders Disorders characterized by proliferation of lymphoid tissue, general or unspecified. Duncan's Syndrome,X-Linked Lymphoproliferative Syndrome,Duncan Disease,Epstein-Barr Virus Infection, Familial Fatal,Epstein-Barr Virus-Induced Lymphoproliferative Disease In Males,Familial Fatal Epstein-Barr Infection,Immunodeficiency 5,Immunodeficiency, X-Linked Progressive Combined Variable,Lymphoproliferative Disease, X-Linked,Lymphoproliferative Syndrome, X-Linked, 1,Purtilo Syndrome,X-Linked Lymphoproliferative Disease,X-Linked Lymphoproliferative Disorder,Disease, Duncan,Disease, X-Linked Lymphoproliferative,Diseases, X-Linked Lymphoproliferative,Disorder, Lymphoproliferative,Disorder, X-Linked Lymphoproliferative,Disorders, Lymphoproliferative,Disorders, X-Linked Lymphoproliferative,Epstein Barr Virus Induced Lymphoproliferative Disease In Males,Epstein Barr Virus Infection, Familial Fatal,Familial Fatal Epstein Barr Infection,Immunodeficiency 5s,Immunodeficiency, X Linked Progressive Combined Variable,Lymphoproliferative Disease, X Linked,Lymphoproliferative Diseases, X-Linked,Lymphoproliferative Disorder,Lymphoproliferative Disorder, X-Linked,Lymphoproliferative Disorders, X-Linked,Lymphoproliferative Syndrome, X-Linked,Lymphoproliferative Syndromes, X-Linked,Purtilo Syndromes,Syndrome, Purtilo,Syndrome, X-Linked Lymphoproliferative,Syndromes, Purtilo,Syndromes, X-Linked Lymphoproliferative,X Linked Lymphoproliferative Disease,X Linked Lymphoproliferative Disorder,X Linked Lymphoproliferative Syndrome,X-Linked Lymphoproliferative Diseases,X-Linked Lymphoproliferative Disorders,X-Linked Lymphoproliferative Syndromes
D009697 Nucleolus Organizer Region The chromosome region which is active in nucleolus formation and which functions in the synthesis of ribosomal RNA. Nucleolar Organizer,Nucleolar Organizers,Nucleolus Organizer Regions,Organizer Region, Nucleolus,Organizer Regions, Nucleolus,Organizer, Nucleolar,Organizers, Nucleolar,Region, Nucleolus Organizer,Regions, Nucleolus Organizer
D005770 Gastrointestinal Neoplasms Tumors or cancer of the GASTROINTESTINAL TRACT, from the MOUTH to the ANAL CANAL. Gastrointestinal Cancer,Cancer of Gastrointestinal Tract,Cancer of the Gastrointestinal Tract,Neoplasms, Gastrointestinal,Cancer, Gastrointestinal,Cancers, Gastrointestinal,Gastrointestinal Cancers,Gastrointestinal Neoplasm,Gastrointestinal Tract Cancer,Gastrointestinal Tract Cancers,Neoplasm, Gastrointestinal
D005871 Castleman Disease Large benign, hyperplastic lymph nodes. The more common hyaline vascular subtype is characterized by small hyaline vascular follicles and interfollicular capillary proliferations. Plasma cells are often present and represent another subtype with the plasma cells containing IgM and IMMUNOGLOBULIN A. Angiofollicular Lymphoid Hyperplasia,Castleman's Tumor,Giant Lymph Node Hyperplasia,Hyperplasia, Giant Lymph Node,Lymph Node Hyperplasia, Giant,Angiofollicular Lymph Hyperplasia,Angiofollicular Lymph Node Hyperplasia,Castleman's Disease,Castlemans Disease,Angiofollicular Lymph Hyperplasias,Angiofollicular Lymphoid Hyperplasias,Castleman Tumor,Castlemans Tumor,Disease, Castlemans,Hyperplasia, Angiofollicular Lymph,Hyperplasia, Angiofollicular Lymphoid,Lymph Hyperplasia, Angiofollicular,Lymphoid Hyperplasia, Angiofollicular,Tumor, Castleman's
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D016393 Lymphoma, B-Cell A group of heterogeneous lymphoid tumors generally expressing one or more B-cell antigens or representing malignant transformations of B-lymphocytes. B-Cell Lymphoma,B Cell Lymphoma,B-Cell Lymphomas,Lymphoma, B Cell,Lymphomas, B-Cell
D016622 Silver Staining The use of silver, usually silver nitrate, as a reagent for producing contrast or coloration in tissue specimens. Silver Nitrate Staining,Nitrate Staining, Silver,Staining, Silver,Staining, Silver Nitrate

Related Publications

H Takahashi, and S Fujita, and H Okabe, and N Tsuda, and F Tezuka
January 1995, Folia histochemica et cytobiologica,
H Takahashi, and S Fujita, and H Okabe, and N Tsuda, and F Tezuka
January 1996, Polish journal of pathology : official journal of the Polish Society of Pathologists,
H Takahashi, and S Fujita, and H Okabe, and N Tsuda, and F Tezuka
October 1992, Nihon rinsho. Japanese journal of clinical medicine,
H Takahashi, and S Fujita, and H Okabe, and N Tsuda, and F Tezuka
January 1994, Folia histochemica et cytobiologica,
H Takahashi, and S Fujita, and H Okabe, and N Tsuda, and F Tezuka
March 1994, Zentralblatt fur Pathologie,
H Takahashi, and S Fujita, and H Okabe, and N Tsuda, and F Tezuka
January 1992, Cytopathology : official journal of the British Society for Clinical Cytology,
H Takahashi, and S Fujita, and H Okabe, and N Tsuda, and F Tezuka
October 1998, The American Journal of dermatopathology,
H Takahashi, and S Fujita, and H Okabe, and N Tsuda, and F Tezuka
September 1996, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology,
H Takahashi, and S Fujita, and H Okabe, and N Tsuda, and F Tezuka
March 1994, Oncology reports,
H Takahashi, and S Fujita, and H Okabe, and N Tsuda, and F Tezuka
January 1996, Folia medica Cracoviensia,
Copied contents to your clipboard!